Dr. Gauri J. Kiefer, MD

Dr. Kiefer practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Kiefer's NPI, 1780655829, was assigned on January 27, 2006. Dr. Kiefer holds Pennsylvania license MD055420L.

Dr. Kiefer's primary practice is UPMC Magee-Womens Hospital, at 300 Halket Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 641-4010.

Dr. Kiefer's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Kiefer is also affiliated with UPMC Presbyterian. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Dr. Kiefer to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kiefer practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kiefer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kiefer is licensed in Pennsylvania.

CMS data shows 3,005 Medicare services from Dr. Kiefer across 19 procedure codes in 2024, for 282 Medicare patients. Medicare paid $118,268 for them.

CMS counts 282 Medicare patients who saw Dr. Kiefer in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kiefer's median patient age at 72, with 64% women.

In 2024, Dr. Kiefer wrote 1,995 Medicare Part D claims for 382 patients. 83% of them were for generic drugs. CMS names the drug for 1,779 of them, across 34 drugs with 11 or more claims each, at $3,519,751 in total drug cost. In 2023, CMS named 1,522 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 64 out of 100 for Dr. Kiefer for performance year 2024, reported as part of a group. Dr. Kiefer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Kiefer, published from 2020 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Depression, Caregivers and Fatigue. Dr. Kiefer's most frequent co-authors are Vincent Edgar Reyes, MD, Samer T. Tohme, MD and Gaurav Goel.

Dmand AI links Dr. Kiefer to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 30 general payments to Dr. Kiefer from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. AstraZeneca Pharmaceuticals LP paid the most, $204.